Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease

NCT04768907 is registered in ClinicalTrials.gov with MaaT Pharma as lead sponsor.

NCT NCT04768907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04768907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease
Lead sponsor
MaaT Pharma
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft versus host disease in intestine, steroid refractory gvhd